Description
The Food and Drug Administration Amendments Act of 2007 gave FDA the authority to require a Risk Evaluation and Mitigation Strategy (REMS) from manufacturers to ensure that the benefits of a drug or biological product outweigh its risks.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| PDF File | ucm111350.htm | Open resource |